NNNN

Healthcare Medical Instruments & Supplies

Anbio Biotechnology

$4.83

-0.99 -17.01% today

Price History

Not enough data

Key Stats

Market Cap

211.99M

Avg Volume

146,578

P/E (TTM)

32.20

EPS

$0.15

52W High

$44.73

52W Low

$4.66

Div. Yield

0.0%

Valuation

P/B Ratio

7.03

P/S Ratio

24.52

EV/Revenue

22.81

Margins

Gross Margin 87.2%

Operating Margin 59.1%

Net Margin 74.1%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

73.9%

Return on Equity

27.0%

Return on Assets

14.7%

Liquidity & Leverage

Current Ratio

344.31

Quick Ratio

177.13

Total Cash

11.90M

Total Debt

About

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.